Technology pipeline

New linker for high DAR ADCs

Multilink™ is a new cleavable linker platform suited for multidrug attachment and compatible with any conjugation technology to produce ADCs with high DAR (drug-to-antibody ratio).

A versatile conjugation platform for antibodies

AbYlink™ is an antibody conjugation technology ideally suited for therapeutic and diagnostic applications. Thanks to AbYlink™, cytotoxic or imaging cargos can be selectively attached to the Fc portion of any IgG without prior modification of the antibody. This technology preserves the original affinity of the antibody to its target.